Rimah Melati Ab Ghani

Rimah Melati Ab Ghani

Auto-generated profile, based on publicly available information

Rimah Melati Ab Ghani

Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
AAAisha Fadhilah Abang Abdullah
Aisha Fadhilah Abang Abdullah
NMNor Asiah Muhamad
Nor Asiah Muhamad
RGRimah Melati Ab Ghani
Rimah Melati Ab Ghani
NMNur Hasnah Maamor
Nur Hasnah Maamor
FLFatin Norhasny Leman
Fatin Norhasny Leman
SSSalmiah MD Said
Salmiah MD Said
Background: Allergic diseases affect around 40% of the pediatric population worldwide. The coexistence of asthma, allergic rhinitis, eczema, and food allergy renders allergy treatment and prevention challenging. Infant feeding strategies recommend avoiding allergenic foods to prevent allergy development and anaphylaxis. However, recent evidence suggests that early consumption of food allergens during weaning in infants aged 4-6 months could result in food tolerance, thus reducing the risk of developing allergies. Objective: The aim of this study is to systematically review and carry out a meta-analysis of evidence on the outcome of early food introduction for preventing childhood allergic diseases. Methods: We will conduct a systematic review of interventions through a comprehensive search of various databases including PubMed, Embase, Scopus, CENTRAL, PsycINFO, CINAHL, and Google Scholar to identify potential studies. The search will be performed for any eligible articles from the earliest published articles up to the latest available studies in 2023. We will include randomized controlled trials (RCTs), cluster RCTs, non-RCTs, and other observational studies that assess the effect of early food introduction to prevent childhood allergic diseases. Results: Primary outcomes will include measures related to the effect of childhood allergic diseases (ie, asthma, allergic rhinitis, eczema, and food allergy). PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines will be followed for study selection. All data will be extracted using a standardized data extraction form and the quality of the studies will be assessed using the Cochrane Risk of Bias tool. A summary of findings table will be generated for the following outcomes: (1) total number of allergic diseases, (2) rate of sensitization, (3) total number of adverse events, (4) improvement of health-related quality of life, and (5) all-cause mortality. Descriptive and meta-analyses will be performed using a random-effects model in Review Manager (Cochrane). Heterogeneity among selected studies will be assessed using the I2 statistic and explored through meta-regression and subgroup analyses. Data collection is expected to start in June 2023. Conclusions: The results acquired from this study will contribute to the existing literature and harmonize recommendations for infant feeding with regard to the prevention of childhood allergic diseases. Trial Registration: PROSPERO CRD42021256776; https://tinyurl.com/4j272y8a International Registered Report Identifier (IRRID): PRR1-10.2196/46816

4 November 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
CJChandrika Jeevananthan
Chandrika Jeevananthan
NMNor Asiah Muhamad
Nor Asiah Muhamad
MJMohd hasni jaafar
Mohd hasni jaafar
RHRozita Hod
Rozita Hod
RGRimah Melati Ab Ghani
Rimah Melati Ab Ghani
ZIZaleha Md Isa
Zaleha Md Isa
Introduction The current global pandemic of the virus that emerged from Hubei province in China has caused coronavirus disease in 2019 (COVID-19), which has affected a total number of 900 036 people globally, involving 206 countries and resulted in a cumulative of 45 693 deaths worldwide as of 3 April 2020. The mode of transmission is identified through airdrops from patients’ body fluids such as during sneezing, coughing and talking. However, the relative importance of environmental effects in the transmission of the virus has not been vastly studied. In addition, the role of temperature and humidity in air-borne transmission of infection is presently still unclear. This study aims to identify the effect of temperature, humidity and air quality in the transmission of SARS-CoV-2. Methods and analysis We will systematically conduct a comprehensive literature search using various databases including PubMed, EMBASE, Scopus, CENTRAL and Google Scholar to identify potential studies. The search will be performed for any eligible articles from the earliest published articles up to latest available studies in 2020. We will include all the observational studies such as cohort case–control and cross-sectional studies that explains or measures the effects of temperature and/or humidity and/or air quality and/or anthropic activities that is associated with SARS-CoV-2. Study selection and reporting will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and Meta-Analysis of Observational Studies in Epidemiology guideline. All data will be extracted using a standardised data extraction form and quality of the studies will be assessed using the Newcastle-Ottawa Scale guideline. Descriptive and meta-analysis will be performed using a random effect model in Review Manager File. Ethics and dissemination No primary data will be collected, and thus no formal ethical approval is required. The results will be disseminated through a peer-reviewed publication and conference presentation. PROSPERO registration number CRD42020176756.

14 April 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
NMNor Asiah Muhamad
Nor Asiah Muhamad
NSNatasha Subhas
Natasha Subhas
NMNormi Mustapha
Normi Mustapha
NANorni Abdullah
Norni Abdullah
MRMuhammad Arif Muhamad Rasat
Muhammad Arif Muhamad Rasat
KNKher Shean Ng
Kher Shean Ng
The COVID-19 pandemic has become the greatest challenge of the new millennium. Most healthcare workers (HCWs) experienced unprecedented levels of workload since the pandemic. This study aims to identify the prevalence and factors of depression, anxiety and stress among HCWs in Malaysian healthcare facilities in the midst of the pandemic due to the SARs-CoV-2. An emergency response programme on mental health was conducted from June to September 2020. A standardized data collection form was distributed among the HCWs in the government hospital in Klang Valley. The form contained basic demographic information and the self-reported Malay version of the Depression, Anxiety and Stress scale (BM DASS-21). Of the1,300 staff who attended the Mental Health and Psychosocial Support in Covid-19 (MHPSS COVID-19) programme, 996 staff (21.6% male, 78.4% female) completed the online survey (response rate: 76.6%). Result showed that staff aged above 40 years old were almost two times more likely to have anxiety (AOR = 1.632; 95% CI = 1.141–2.334, p:0.007) and depression (AOR = 1.637; 95% CI = 1.1.06–2.423, p:0.014) as compared to staff who were less than 40 years old. Those who had direct involvement with COVID-19 patients were likely to suffer stress (AOR = 0.596; 95% CI = 0.418–0.849, p:0.004), anxiety (AOR = 0.706; 95% Ci = 0.503–0.990, p:0.044) and depression (AOR = 0.630; 95% Ci = 0.427–0.928, p:0.019). HCWs with stress (AOR = 0.638; 95% CI of 0.476–0.856, p = 0.003), anxiety (AOR = 0.720; 95% CI 0.542–0.958, p = 0.024) and depression (AOR = 0.657; 95% CI 0.480–0.901, p = 0.009) showed less confidence to treat critically ill patients and need psychological help during outbreak. This study showed the importance of psychosocial support to reduce psychological distress among HCWs when working or coping during the COVID-19 pandemic or outbreak.

27 February 2023 in JMIR Preprints
Verified
Preprint
Open access
AAAisha Fadhilah Abang Abdullah
Aisha Fadhilah Abang Abdullah
NMNor Asiah Muhamad
Nor Asiah Muhamad
RGRimah Melati Ab Ghani
Rimah Melati Ab Ghani
NMNur Hasnah Maamor
Nur Hasnah Maamor
FLFatin Norhasny Leman
Fatin Norhasny Leman
SSSalmiah MD Said
Salmiah MD Said
BACKGROUND Allergic diseases affect around 40% of the pediatric population worldwide. The coexistence of asthma, allergic rhinitis, eczema, and food allergy renders allergy treatment and prevention challenging. Infant feeding strategies recommend avoiding allergenic foods to prevent allergy development and anaphylaxis. However, recent evidence suggests that early consumption of food allergens during weaning in infants aged 4-6 months could result in food tolerance, thus reducing the risk of developing allergies. OBJECTIVE The aim of this study is to systematically review and carry out a meta-analysis of evidence on the outcome of early food introduction for preventing childhood allergic diseases. METHODS We will conduct a systematic review of interventions through a comprehensive search of various databases including PubMed, Embase, Scopus, CENTRAL, PsycINFO, CINAHL, and Google Scholar to identify potential studies. The search will be performed for any eligible articles from the earliest published articles up to the latest available studies in 2023. We will include randomized controlled trials (RCTs), cluster RCTs, non-RCTs, and other observational studies that assess the effect of early food introduction to prevent childhood allergic diseases. RESULTS Primary outcomes will include measures related to the effect of childhood allergic diseases (ie, asthma, allergic rhinitis, eczema, and food allergy). PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines will be followed for study selection. All data will be extracted using a standardized data extraction form and the quality of the studies will be assessed using the Cochrane Risk of Bias tool. A summary of findings table will be generated for the following outcomes: (1) total number of allergic diseases, (2) rate of sensitization, (3) total number of adverse events, (4) improvement of health-related quality of life, and (5) all-cause mortality. Descriptive and meta-analyses will be performed using a random-effects model in Review Manager (Cochrane). Heterogeneity among selected studies will be assessed using the I2 statistic and explored through meta-regression and subgroup analyses. Data collection is expected to start in June 2023. CONCLUSIONS The results acquired from this study will contribute to the existing literature and harmonize recommendations for infant feeding with regard to the prevention of childhood allergic diseases. CLINICALTRIAL PROSPERO CRD42021256776; https://tinyurl.com/4j272y8a INTERNATIONAL REGISTERED REPORT PRR1-10.2196/46816